The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125454614 12545461 4 F 20160613 20160921 20160711 20160926 EXP PHHO2016US009559 SANDOZ 42.33 YR M Y 69.50000 KG 20160926 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125454614 12545461 1 SS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 Oral 500 MG, BID 0 500 MG BID
125454614 12545461 2 SS TACROLIMUS. TACROLIMUS 1 Oral 7 MG, BID 4746 MG Y U 0 7 MG BID
125454614 12545461 3 SS TACROLIMUS. TACROLIMUS 1 Oral 7 MG, BID 4746 MG Y U 0 7 MG BID
125454614 12545461 4 SS TACROLIMUS. TACROLIMUS 1 Oral 6 MG, BID 4746 MG Y U 0 6 MG BID
125454614 12545461 5 SS TACROLIMUS. TACROLIMUS 1 Oral 3 MG, UNK 4746 MG Y U 0 3 MG
125454614 12545461 6 SS TACROLIMUS. TACROLIMUS 1 Oral 2 MG, UNK 4746 MG Y U 0 2 MG
125454614 12545461 7 SS TACROLIMUS. TACROLIMUS 1 Oral 2 MG, BID 4746 MG Y U 0 2 MG BID
125454614 12545461 8 SS TACROLIMUS. TACROLIMUS 1 Oral 1 MG, BID 4746 MG Y U 0 1 MG BID
125454614 12545461 9 SS PREDNISONE. PREDNISONE 1 Oral 10 MG, BID 0 10 MG BID
125454614 12545461 10 PS AMLODIPINE AMLODIPINE BESYLATE 1 Oral 10 MG, QD 2840 MG 76859 10 MG QD
125454614 12545461 11 SS LABETALOL LABETALOLLABETALOL HYDROCHLORIDE 1 Oral 100 MG, BID 67400 MG 0 100 MG BID
125454614 12545461 12 SS VORICONAZOLE. VORICONAZOLE 1 Oral 400 MG, BID Y 0 400 MG BID
125454614 12545461 13 SS VORICONAZOLE. VORICONAZOLE 1 Oral 200 MG, BID Y 0 200 MG BID
125454614 12545461 14 SS VORICONAZOLE. VORICONAZOLE 1 Oral 300 MG, QD Y 0 300 MG QD
125454614 12545461 15 SS NO TREATMENT RECEIVED UNSPECIFIED INGREDIENT 1 Unknown NO TREATMENT D 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125454614 12545461 1 Renal transplant
125454614 12545461 2 Renal transplant
125454614 12545461 9 Renal transplant
125454614 12545461 10 Hypertension
125454614 12545461 11 Hypertension
125454614 12545461 12 Pneumonia
125454614 12545461 15 Renal transplant

Outcome of event

Event ID CASEID OUTC COD
125454614 12545461 LT
125454614 12545461 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125454614 12545461 Acute kidney injury
125454614 12545461 Pneumonia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125454614 12545461 1 20150719 0
125454614 12545461 2 20150711 20160613 0
125454614 12545461 3 20160616 0
125454614 12545461 4 20160619 20160811 0
125454614 12545461 5 20160814 0
125454614 12545461 6 20160816 0
125454614 12545461 7 20160817 20160825 0
125454614 12545461 8 20160906 0
125454614 12545461 9 20150713 0
125454614 12545461 10 20150904 20160613 0
125454614 12545461 11 20150713 20160613 0
125454614 12545461 12 20160816 20160818 0
125454614 12545461 13 20160818 20160825 0
125454614 12545461 14 20160826 20160828 0